Cited by 527Mitochondrial Function and PathologyCardiac Fibrosis and RemodelingNitric Oxide and Endothelin Effects

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure

Open access

Dai, Dao-Fu, Johnson, Simon C., Villarin, Jason J., Chin, Michael T., Nieves-Cintrón, Madeline, Chen, Tony, Marcinek, David J., Dorn, Gerald W., Kang, Y. James, Prolla, Tomas A., Santana, Luis F., Rabinovitch, Peter S.·2011·Circulation Research

DOI 10.1161/circresaha.110.232306PMC PMC3785241

Open this paper in CoChat — free account Open PDF

Abstract

Rationale: Mitochondrial dysfunction has been implicated in several cardiovascular diseases; however, the roles of mitochondrial oxidative stress and DNA damage in hypertensive cardiomyopathy are not well understood. Objective: We evaluated the contribution of mitochondrial reactive oxygen species (ROS) to cardiac hypertrophy and failure by using genetic mouse models overexpressing catalase targeted to mitochondria and to peroxisomes. Methods and Results: Angiotensin II increases mitochondrial ROS in cardiomyocytes, concomitant with increased mitochondrial protein carbonyls, mitochondrial DNA deletions, increased autophagy and signaling for mitochondrial biogenesis in hearts of angiotensin II–treated mice. The causal role of mitochondrial ROS in angiotensin II–induced cardiomyopathy is shown by the observation that mice that overexpress catalase targeted to mitochondria, but not mice that overexpress wild-type peroxisomal catalase, are resistant to cardiac hypertrophy, fibrosis and mitochondrial damage induced by angiotensin II, as well as heart failure induced by overexpression of Gαq. Furthermore, primary damage to mitochondrial DNA, induced by zidovudine administration or homozygous mutation of mitochondrial polymerase γ, is also shown to contribute directly to the development of cardiac hypertrophy, fibrosis and failure. Conclusions: These data indicate the critical role of mitochondrial ROS in cardiac hypertrophy and failure and support the potential use of mitochondrial-targeted antioxidants for prevention and treatment of hypertensive cardiomyopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circresaha.110.232306

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging
Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., Hofer, T., Seo, A. Y., Sullivan, R., Jobling, W. A., et al. (2005) · Science · doi:10.1126/science.1112125 · Cited by 2,165
Self-citation
Extension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724
Self-citation
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
Mitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,672
Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253
Self-citation
Transcriptional control of mitochondrial biogenesis: the central role of PGC-1
Ventura-Clapier, R., Garnier, A., & Veksler, V. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn098 · Cited by 932

Show all 35 references

Sorted by citations

Items 201–300 of 526

A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition
Gupta, A. K., & Houston, B. A. (2017) · Heart Failure Reviews · doi:10.1007/s10741-017-9623-6 · Cited by 51
PGC-1α activator ZLN005 promotes maturation of cardiomyocytes derived from human embryonic stem cells
Liu, Y., Bai, H., Guo, F., Thai, P. N., Luo, X., Zhang, P., Yang, C. C., Feng, X., Zhu, D., Guo, J. X., et al. (2020) · Aging · doi:10.18632/aging.103088 · Cited by 52
Targeted inhibition of calpain in mitochondria alleviates oxidative stress-induced myocardial injury
Zheng, D., Cao, T., Zhang, L., Fan, G., Qiu, J., & Peng, T. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00526-y · Cited by 51
Influence of cardiometabolic comorbidities on myocardial function, infarction, and cardioprotection: Role of cardiac redox signaling
Andreadou, I., Daiber, A., Baxter, G. F., Brizzi, M. F., Lisa, F. D., Kaludercic, N., Lazou, A., Varga, Z. V., Zuurbier, C. J., Schulz, R., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.012 · Cited by 52
A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling
Gao, J., Zhang, K., Wáng, Y., Guo, R., Liu, H., Jia, C., Sun, X., Wu, C., Wang, W., Du, J., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104739 · Cited by 49
Redox-Resistant SERCA [Sarco(endo)plasmic Reticulum Calcium ATPase] Attenuates Oxidant-Stimulated Mitochondrial Calcium and Apoptosis in Cardiac Myocytes and Pressure Overload–Induced Myocardial Failure in Mice
Goodman, J. B., Qin, F., Morgan, R. J., Chambers, J. M., Croteau, D., Siwik, D. A., Hobai, I. A., Panagia, M., Luptak, I., Bachschmid, M. M., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.048183 · Cited by 49
Epac2-Rap1 Signaling Regulates Reactive Oxygen Species Production and Susceptibility to Cardiac Arrhythmias
Yang, Z., Kirton, H. M., Al‐Owais, M. M., Thireau, J., Richard, S., Peers, C., & Steele, D. S. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6485 · Cited by 49
Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway
Yang, J., Xu, J., Han, X., Wang, H., Zhang, Y., Dong, J., Deng, Y., & Wang, J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01315 · Cited by 48
Adiponectin Attenuates Angiotensin II-Induced Vascular Smooth Muscle Cell Remodeling through Nitric Oxide and the RhoA/ROCK Pathway
Nour‐Eldine, W., Ghantous, C. M., Zibara, K., Dib, L., Issa, H., Itani, H. A., Zein, N. E., & Zeidan, A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00086 · Cited by 48
Angiotensin-(1–9) prevents cardiomyocyte hypertrophy by controlling mitochondrial dynamics via miR-129-3p/PKIA pathway
Sotomayor-Flores, C., Rivera-Mejías, P., Vásquez-Trincado, C., López‐Crisosto, C., Morales, P. E., Pennanen, C., Polakovičová, I., Aliaga-Tobar, V., García, L., Roa, J. C., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0522-3 · Cited by 48
Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
Han, W., Du, C., Yingguo, Z., Ran, L., Wang, Y., Xiong, J., Wu, Y., Lan, Q., Wang, Y., Wang, L., et al. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.03.006 · Cited by 46
Myocardial reverse remodeling: how far can we rewind?
Gonçalves‐Rodrigues, P., Leite-Moreira, A. F., & Falcão‐Pires, I. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00696.2015 · Cited by 48
Extracellular vesicles DJ-1 derived from hypoxia-conditioned hMSCs alleviate cardiac hypertrophy by suppressing mitochondria dysfunction and preventing ATRAP degradation
Lu, Y., Zhang, J., Han, B., Yu, Y., Zhao, W., Wu, T., Mao, Y., & Zhang, F. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106607 · Cited by 45
Isocitrate dehydrogenase 2 deficiency aggravates prolonged high-fat diet intake-induced hypertension
Noh, M. R., Kong, M. J., Han, S. J., Kim, J. I., & Park, K. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101548 · Cited by 45
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
Giannotta, G., Murrone, A., & Giannotta, N. (2023) · Vaccines · doi:10.3390/vaccines11040747 · Cited by 45
Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
Buttari, B., Tramutola, A., Rojo, A. I., Chondrogianni, N., Saha, S., Berry, A., Giona, L., Miranda, J. P., Profumo, E., Davinelli, S., et al. (2025) · Biomolecules · doi:10.3390/biom15010113 · Cited by 49
Mitochondrion as a Target for Heart Failure Therapy – Role of Protein Lysine Acetylation –
Lee, C. F., & Tian, R. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0742 · Cited by 46
Mitochondria-Targeted Catalase Reverts the Neurotoxicity of hSOD1G93A Astrocytes without Extending the Survival of ALS-Linked Mutant hSOD1 Mice
Pehar, M., Beeson, G. C., Beeson, C., Johnson, J. A., & Vargas, M. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103438 · Cited by 44
IDH2 deficiency impairs mitochondrial function in endothelial cells and endothelium-dependent vasomotor function
Park, J.-B., Nagar, H., Choi, S., Jung, S.-B., Kim, H., Kang, S. K., Lee, J. W., Lee, J. H., Park, J., Irani, K., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.02.017 · Cited by 47
Adenosine A1receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1‐adrenoceptor stimulationin vivo
Puhl, S., Kazakov, A., Müller, A., Fries, P., Wagner, D. R., Böhm, M., Maack, C., & Devaux, Y. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13339 · Cited by 43
Cardiomyocyte hypertrophy induced by Endonuclease G deficiency requires reactive oxygen radicals accumulation and is inhibitable by the micropeptide humanin
Blasco, N., Cámara, Y., Núñez, E., Beà, A., Barés, G., Forné, C., Ruiz‐Meana, M., Girón, C., Barba, I., García‐Arumí, E., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.02.021 · Cited by 43
Mechanisms underlying the pathophysiology of heart failure with preserved ejection fraction: the tip of the iceberg
Miranda‐Silva, D., Lima, T., Rodrigues, P., Leite-Moreira, A. F., & Falcão‐Pires, I. (2021) · Heart Failure Reviews · doi:10.1007/s10741-020-10042-0 · Cited by 45
The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
Adamcová, M., Kawano, I., & Šimko, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094762 · Cited by 44
Exposure to zinc oxide nanoparticles (ZnO-NPs) induces cardiovascular toxicity and exacerbates pathogenesis – Role of oxidative stress and MAPK signaling
Nagarajan, M., Maadurshni, G. B., Tharani, G. K., Udhayakumar, I., Kumar, G., Mani, K. P., Sivasubramanian, J., & Manivannan, J. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109719 · Cited by 44
Targeting cPLA2 derived lipid hydroperoxides as a potential intervention for sarcopenia
Pharaoh, G. A., Brown, J. L., Sataranatarajan, K., Kneis, P., Bian, J., Ranjit, R., Hadad, N., Georgescu, C., Rabinovitch, P. S., Ran, Q., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70792-7 · Cited by 43
Self-citation
Oxidative stress and atrial fibrillation
Pfenniger, A., Yoo, S., & Arora, R. (2024) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2024.09.011 · Cited by 49
Mitochondrial‐targeted catalase is good for the old mouse proteome, but not for the young: ‘reverse’ antagonistic pleiotropy?
Basisty, N., Dai, D., Gagnidze, A., Gitari, L., Fredrickson, J., Maina, Y., Beyer, R. P., Emond, M. J., Hsieh, E. J., MacCoss, M. J., et al. (2016) · Aging Cell · doi:10.1111/acel.12472 · Cited by 41
Self-citation
Adrenergic Regulation of Drp1-Driven Mitochondrial Fission in Cardiac Physio-Pathology
Jhun, B. S., O‐Uchi, J., Adaniya, S. M., Cypress, M. W., & Yoon, Y. (2018) · Antioxidants · doi:10.3390/antiox7120195 · Cited by 43
Quality control systems in cardiac aging
Quarles, E. K., Dai, D., Tocchi, A., Basisty, N., Gitari, L., & Rabinovitch, P. S. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.02.003 · Cited by 42
Self-citation
Targeting Mitochondria for Cardioprotection: Examining the Benefit for Patients
Dongworth, R. K., Hall, A. R., Burke, N., & Hausenloy, D. J. (2014) · Future Cardiology · doi:10.2217/fca.14.6 · Cited by 40
Antioxidant catalase rescues against high fat diet-induced cardiac dysfunction via an IKKβ-AMPK-dependent regulation of autophagy
Liang, L., Shou, X., Zhao, H., Ren, G.-Q., Wang, J.-B., Wang, X.-H., Ai, W., Maris, J. R., Hueckstaedt, L. K., Ma, A., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.06.027 · Cited by 40
Cardiomyocyte autophagy: metabolic profit and loss
Wang, Z. V., Ferdous, A., & Hill, J. A. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9350-y · Cited by 39
Cardiac Metabolic Alterations in Hypertensive Obese Pigs
Zhang, X., Li, Z.-L., Eirin, A., Ebrahimi, B., Pawar, A. S., Zhu, X.-Y., Lerman, A., & Lerman, L. O. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05478 · Cited by 38
Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Daiber, A., Steven, S., Euler, G., & Schulz, R. (2021) · Current Pharmaceutical Design · doi:10.2174/1381612827666210125155821 · Cited by 40
Chronic Diclofenac Exposure Increases Mitochondrial Oxidative Stress, Inflammatory Mediators, and Cardiac Dysfunction
Thai, P. N., Ren, L., Xu, W., Overton, J. L., Timofeyev, V., Nader, C. E., Haddad, M., Yang, J., Gomes, A. V., Hammock, B. D., et al. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07253-4 · Cited by 38
Trim65 attenuates isoproterenol-induced cardiac hypertrophy by promoting autophagy and ameliorating mitochondrial dysfunction via the Jak1/Stat1 signaling pathway
Liu, H., Zhou, Z., Deng, H., Tian, Z., Wu, Z.-F., Liu, X., Ren, Z., & Jiang, Z. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175735 · Cited by 38
Cardiac steatosis potentiates angiotensin II effects in the heart
Glenn, D. J., Cardema, M. C., Ni, W., Zhang, Y., Yeghiazarians, Y., Grapov, D., Fiehn, O., & Gardner, D. G. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00742.2014 · Cited by 40
Angiotensin II induces mitochondrial oxidative stress and mtDNA damage in osteoblasts by inhibiting SIRT1–FoxO3a–MnSOD pathway
Li, Y., Shen, G., Chen, Y., Li, G., Shen, J., Gong, J., & Xu, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.123 · Cited by 39
Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome
Ilkun, O. L., Wilde, N., Tuinei, J., Pires, K. M. P., Zhu, Y., Bugger, H., Soto, J. E., Wayment, B. E., Olsen, C. D., Litwin, S. E., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.05.012 · Cited by 39
Oxidative Stress and Endoplasmic Reticular Stress Interplay in the Vasculopathy of Hypertension
Camargo, L. L., Wang, Y., Rios, F. J. O., McBride, M., Montezano, A. C. I., & Touyz, R. M. (2023) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2023.10.012 · Cited by 35
Recombinant mitochondrial transcription factor A protein inhibits nuclear factor of activated T cells signaling and attenuates pathological hypertrophy of cardiac myocytes
Fujino, T., Ide, T., Yoshida, M., Onitsuka, K., Tanaka, A., Hata, Y., Nishida, M., Takehara, T., Kanemaru, T., Kitajima, N., et al. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.06.002 · Cited by 37
Zebrafish heart failure models: opportunities and challenges
Shi, X., Chen, R., Zhang, Y., Yun, J., Brand‐Arzamendi, K., Liu, X., & Wen, X. (2018) · Amino Acids · doi:10.1007/s00726-018-2578-7 · Cited by 40
Differential Effects of Sacubitril/Valsartan on Diastolic Function in Mice With Obesity-Related Metabolic Heart Disease
Croteau, D., Qin, F., Chambers, J. M., Kallick, E., Luptak, I., Panagia, M., Pimentel, D. R., Siwik, D. A., & Colucci, W. S. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.07.006 · Cited by 39
Enhancing Mitochondrial Health to Treat Hypertension
Eirin, A., Lerman, A., & Lerman, L. O. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0889-4 · Cited by 36
Epigenetically dysregulated genes and pathways implicated in the pathogenesis of non-syndromic high myopia
Vishweswaraiah, S., Swierkowska, J., Ratnamala, U., Mishra, N. K., Guda, C., Chettiar, S. S., Johar, K., Mrugacz, M., Karolak, J. A., Gajęcka, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40299-x · Cited by 36
Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome
Shi, S., Zhang, B., Li, Y., Xu, X., Lv, J., Jia, Q., Chai, R., Xue, W., Li, Y., Wang, Y., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.837270 · Cited by 35
Class III PI 3K‐mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure
Yu, P., Zhang, Y., Li, C., Li, Y., Jiang, S., Zhang, X., Ding, Z., Tu, F., Wu, J., Gao, X., et al. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12547 · Cited by 35
Regulation of Autophagy by Metabolic and Stress Signaling Pathways in the Heart
Lee, Y., Lee, H.-Y., & Gustafsson, Å. B. (2012) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318256cdd0 · Cited by 33
Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism
Karwi, Q. G., Joerg, A. R., & Lopaschuk, G. D. (2019) · Biochemical Journal · doi:10.1042/bcj20180617 · Cited by 38
Curcumin Management of Myocardial Fibrosis and its Mechanisms of Action: A Review
Yu, Y., Sun, J., Wang, R., Liu, J., Wang, P., & Wang, C. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500861 · Cited by 38
Adeno-associated virus-mediated delivery of anti-miR-199a tough decoys attenuates cardiac hypertrophy by targeting PGC-1alpha
Yan, H., Wang, H., Zhu, X., Huang, J., Li, Y., Zhou, K., Hua, Y., Yan, F., Wang, D., & Luo, Y. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.007 · Cited by 35
A new non-canonical pathway of Gαq protein regulating mitochondrial dynamics and bioenergetics
Benincá, C., Planagumà, J., Shuck, A. D. F., Acín‐Pérez, R., Muñoz, J. P., de Almeida, M. M., Brown, J. H., Murphy, A. N., Zorzano, A., Enrı́quez, J. A., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.01.009 · Cited by 34
1-Deoxynojirimycin promotes cardiac function and rescues mitochondrial cristae in mitochondrial hypertrophic cardiomyopathy
Zhuang, Q., Guo, F., Fu, L., Dong, Y., Xie, S., Ding, X., Hu, S., Zhou, X. D., Jiang, Y., Zhou, H., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci164660 · Cited by 34
Mitochondrial Ca2+ Uniporter–Dependent Energetic Dysfunction Drives Hypertrophy in Heart Failure
Alves‐Figueiredo, H., Silva‐Platas, C., Estrada, M., Oropeza‐Almazán, Y., Ramos-González, M., Bernal‐Ramírez, J., Vázquez‐Garza, E., Téllez, A., Salazar‐Ramírez, F., Méndez‐Fernández, A., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.01.007 · Cited by 35
Regulation of Monocyte Adhesion and Migration by Nox4
Lee, C. F., Ullevig, S. L., Kim, H. S., & Asmis, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066964 · Cited by 35
Pathways for salvage and protection of the heart under stress: novel routes for cardiac rejuvenation
Cannata, A. N., Camparini, L., Sinagra, G., Giacca, M., & Loffredo, F. S. (2016) · Cardiovascular Research · doi:10.1093/cvr/cvw106 · Cited by 34
Attenuating persistent sodium current–induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress
Avula, U. M. R., Dridi, H., Chen, B.-X., Yuan, Q., Katchman, A. N., Reiken, S. R., Desai, A. D., Parsons, S., Baksh, H., Ma, E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147371 · Cited by 35
Mitochondrial medicine: “from bench to bedside” 3PM-guided concept
Shao, Q., Noah, M. L. N., Golubnitschaja, O., & Zhan, X. (2025) · The EPMA Journal · doi:10.1007/s13167-025-00409-4 · Cited by 36
Melatonin alleviates angiotensin-II-induced cardiac hypertrophy via activating MICU1 pathway
Yang, Y., Du, J., Xu, R., Shen, Y., Yang, D., Li, D., Hu, H., Pei, H., & Yang, Y. (2020) · Aging · doi:10.18632/aging.202159 · Cited by 33
Hydrogen inhibits isoproterenol-induced autophagy in cardiomyocytes in vitro and in vivo
Zhang, Y., Long, Z., Xu, J., Tan, S., Zhang, N., Li, A., Wang, L., & Wang, T. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7601 · Cited by 32
Mitigation of Cardiovascular Disease and Toxicity through NRF2 Signalling
Roberts, J. A., Rainbow, R. D., & Sharma, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076723 · Cited by 35
Pharmacologic Strategies to Target Oxidative Stress in Heart Failure
Ahmed, Z. U., & Tang, W. H. W. (2012) · Current Heart Failure Reports · doi:10.1007/s11897-011-0081-5 · Cited by 31
TRPC3 deficiency attenuates high salt-induced cardiac hypertrophy by alleviating cardiac mitochondrial dysfunction
Ma, T., Lin, S., Wang, B., Wang, Q., Xia, W., Zhang, H., Cui, Y., He, C., Wu, H., Sun, F., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.018 · Cited by 31
Effects of REDOX in Regulating and Treatment of Metabolic and Inflammatory Cardiovascular Diseases
Wang, K., Dong, Y., Liu, J., Qian, L., Wang, T., Gao, X., Wang, K., & Zhou, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5860356 · Cited by 34
Oxidative Stress-Induced Ferroptosis in Cardiovascular Diseases and Epigenetic Mechanisms
Li, J., Zhou, Y., Wang, H., Lou, J., Lenahan, C., Gao, S., Wang, X., Deng, Y., Chen, H., & Shao, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.685775 · Cited by 31
Central Parkin: The evolving role of Parkin in the heart
Dorn, G. W. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.014 · Cited by 30
Self-citation
Role of angiotensin II in aging
Yi, W., Chen, F., Zhang, H., Tang, P., Yuan, M., Wen, J., Wang, S., & Cai, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1002138 · Cited by 31
Anatomically specific reactive oxygen species production participates in Marfan syndrome aneurysm formation
Emrich, F. C., Penov, K., Arakawa, M., Dhablania, N., Burdon, G., Pedroza, A. J., Koyano, T. K., Kim, Y. M., Raaz, U., Connolly, A. J., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14587 · Cited by 29
LCZ696 ameliorates doxorubicin-induced cardiomyocyte toxicity in rats
Miyoshi, T., Nakamura, K., Amioka, N., Hatipoğlu, Ö. F., Yonezawa, T., Saito, Y., Yoshida, M., Akagi, S., & Ito, H. (2022) · Scientific Reports · doi:10.1038/s41598-022-09094-z · Cited by 29
Deranged cardiac metabolism and the pathogenesis of heart failure
Fragasso, G. (2016) · Cardiac failure review · doi:10.15420/cfr.2016:5:2 · Cited by 29
Sepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the Elderly
Zang, Q. S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500137 · Cited by 28
Interplay of Defective Excitation-Contraction Coupling, Energy Starvation, and Oxidative Stress in Heart Failure
Kohlhaas, M., & Maack, C. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.03.002 · Cited by 29
Combination of angiotensin II and l -NG-nitroarginine methyl ester exacerbates mitochondrial dysfunction and oxidative stress to cause heart failure
Hamilton, D. J., Zhang, A., Li, S., Cao, T. N., Smith, J. A., Vedula, I., Cordero‐Reyes, A. M., Youker, K. A., Torre‐Amione, G., & Gupte, A. A. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00746.2015 · Cited by 28
Zidovudine-Mediated Autophagy Inhibition Enhances Mitochondrial Toxicity in Muscle Cells
Lin, H., Stankov, M. V., Hegermann, J., Budida, R., Panayotova‐Dimitrova, D., Schmidt, R. E., & Behrens, G. M. N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-18 · Cited by 29
Preparation, characterization, and antioxidant and antiapoptotic activities of biosynthesized nano‑selenium by yak-derived Bacillus cereus and chitosan-encapsulated chemically synthesized nano‑selenium
Yang, X., Fu, Y., Zhang, J., Liu, J., Liu, X., Peng, Y., Kyin, S. L., Zhang, M., & Zhou, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124708 · Cited by 28
Role of Endothelial Nitric Oxide Synthase and Collagen Metabolism in Right Ventricular Remodeling due to Pulmonary Hypertension
Nergui, S., Fukumoto, Y., Do.e, Z., Nakajima, S., Shimizu, T., Ikeda, S., Al-Mamun, M. E., & Shimokawa, H. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1586 · Cited by 28
Impaired High‐Density Lipoprotein Anti‐Oxidative Function Is Associated With Outcome in Patients With Chronic Heart Failure
Schrutka, L., Distelmaier, K., Hohensinner, P. J., Sulzgruber, P., Lang, I. M., Maurer, G., Wojta, J., Hülsmann, M., Niessner, A., & Koller, L. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004169 · Cited by 28
WIPI1 is a conserved mediator of right ventricular failure
Tzimas, C., Rau, C. D., Bürgisser, P. E., Jean-Louis, G., Lee, K. J., Chukwuneke, J., Dun, W., Wang, Y., & Tsai, E. J. (2019) · JCI Insight · doi:10.1172/jci.insight.122929 · Cited by 29
Mitochondrial Dysfunction in Arrhythmia and Cardiac Hypertrophy
Wang, X., Yu, Q., Liao, X., Fan, M., Liu, X., Liu, Q., Wang, M., Wu, X., Huang, C.-K., Tan, R., et al. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2412364 · Cited by 26
Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats
Ramalingam, A. R., Budin, S. B., Fauzi, N. M., Ritchie, R. H., & Zainalabidin, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01493 · Cited by 27
Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes
Cui, Y., Wang, P., Li, M., Wang, Y., Tang, X., Cui, J., Chen, Y., & Zhang, T. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115168 · Cited by 27
AZT-induced mitochondrial toxicity: an epigenetic paradigm for dysregulation of gene expression through mitochondrial oxidative stress
Koczor, C. A., Jiao, Z., Fields, E. J., Russ, R. B., Ludaway, T., & Lewis, W. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00045.2015 · Cited by 27
Thymoquinone Protects against Hyperlipidemia‐Induced Cardiac Damage in Low‐Density Lipoprotein Receptor‐Deficient (LDL‐R -/- ) Mice via Its Anti‐inflammatory and Antipyroptotic Effects
Pei, Z., Guo, Y., Zhu, H., Dong, M., Zhang, Q., & Wang, F. (2020) · BioMed Research International · doi:10.1155/2020/4878704 · Cited by 26
Mitochondrial-Targeted Therapies Require Mitophagy to Prevent Oxidative Stress Induced by SOD2 Inactivation in Hypertrophied Cardiomyocytes
Peugnet, V., Chwastyniak, M., Mulder, P. G. H., Lancel, S., Bultot, L., Fourny, N., Renguet, E., Bugger, H., Beseme, O., Loyens, A., et al. (2022) · Antioxidants · doi:10.3390/antiox11040723 · Cited by 26
Autophagy in Heart Failure: Insights into Mechanisms and Therapeutic Implications
Bielawska, M., Warszyńska, M., Stefańska, M., & Błyszczuk, P. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10080352 · Cited by 33
Role of Oxygen Free Radicals, Nitric Oxide and Mitochondria in Mediating Cardiac Alterations During Liver Cirrhosis Induced by Thioacetamide
Amirtharaj, G. J., Natarajan, S. K., Pulimood, A. B., Balasubramanian, K. A., Venkatraman, A., & Ramachandran, A. (2016) · Cardiovascular Toxicology · doi:10.1007/s12012-016-9371-1 · Cited by 28
Mitochondrial Therapies in Heart Failure
von Hardenberg, A., & Maack, C. (2016) · Handbook of experimental pharmacology · doi:10.1007/164_2016_123 · Cited by 26
Branched-Chain Amino Acid Supplementation Ameliorates Angiotensin II-Induced Skeletal Muscle Atrophy
Yamanashi, K., Kinugawa, S., Fukushima, A., Kakutani, N., Takada, S., Obata, Y., Nakano, I., Yokota, T., Kitaura, Y., Shimomura, Y., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117593 · Cited by 25
Enhanced Expression of Catalase in Mitochondria Modulates NF-κB–Dependent Lung Inflammation through Alteration of Metabolic Activity in Macrophages
Han, W., Fessel, J. P., Sherrill, T. P., Kocurek, E. G., Yull, F. E., & Blackwell, T. S. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900820 · Cited by 25
Nanotized PPARα Overexpression Targeted to Hypertrophied Myocardium Improves Cardiac Function by Attenuating the p53-GSK3β-Mediated Mitochondrial Death Pathway
Rana, S., Datta, R., Chaudhuri, R. D., Chatterjee, E., Chawla‐Sarkar, M., & Sarkar, S. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7371 · Cited by 25
Qiliqiangxin Rescues Mouse Cardiac Function by Regulating AGTR1/TRPV1-Mediated Autophagy in STZ-Induced Diabetes Mellitus
Tong, J., Lai, Y. L., Yao, Y., Wang, X.-J., Shi, Y.-S., Han-Jin, H., Gu, J.-Y., Chen, F., & Liu, X. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490822 · Cited by 25
The proteasome activator REGγ accelerates cardiac hypertrophy by declining PP2Acα–SOD2 pathway
Xie, Y., Gao, Y., Gao, R., Yang, W., Dong, Z., Moses, R. E., Sun, A., Li, X., & Ge, J. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0554-8 · Cited by 26
The Crosstalk Between Immune Activation and Metabolism in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC
Fragasso, G., Stolfo, D., Anker, M. S., Bayés‐Genís, A., Chioncel, O. D., Heymans, S. R. B., Jhund, P. S., Lewis, B. S., Lopaschuk, G. D., Lund, L. H., et al. (2025) · European Journal of Heart Failure · doi:10.1002/ejhf.3703 · Cited by 31
The mitochondrial calcium uniporter of pulmonary type 2 cells determines severity of acute lung injury
Islam, M. N., Gusarova, G. A., Das, S., Li, L., Monma, E., Murari, A., Mthunzi, L., Quadri, S. K., Owusu-Ansah, E., Bhattacharya, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33543-y · Cited by 24
Reduction of Rat Cardiac Hypertrophy by Osthol is Related to Regulation of Cardiac Oxidative Stress and Lipid Metabolism
Zhou, F. L., Zhong, W., Xue, J., Gu, Z., & Xie, M.-L. (2012) · Lipids · doi:10.1007/s11745-012-3710-1 · Cited by 24
Exposure of cardiomyocytes to angiotensin II induces over-activation of monoamine oxidase type A: Implications in heart failure
Manni, M. E., Zazzeri, M., Musilli, C., Bigagli, E., Lodovici, M., & Raimondi, L. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.08.022 · Cited by 24
Complications of conventional scleral buckling occuring during and after treatment of rhegmatogenous retinal detachment.
Abdullah, A. S., Jan, S., Qureshi, M. S., Khan, M. T., & Khan, M. D. (2010) · PubMed · Cited by 24
Lack of Contribution of p66shc and Its Mitochondrial Translocation to Ischemia-Reperfusion Injury and Cardioprotection by Ischemic Preconditioning
Boengler, K., Bencsik, P., Pálóczi, J., Kiss, K., Pipicz, M., Pipis, J., Ferdinándy, P., Schlüter, K., & Schulz, R. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00733 · Cited by 25
Scoparone attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts
Fu, B., Su, Y., Ma, X., Mu, C., & Yu, F. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.05.006 · Cited by 24
Cardiac Response to Oxidative Stress Induced by Mitochondrial Dysfunction
Kim, H. K., Nilius, B., Kim, N., Ko, K. S., Rhee, B. D., & Han, J. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2015_5004 · Cited by 26

Authors: Dai, D.-F., Johnson, S. C., Villarin, J. J., Chin, M. T., Nieves-Cintrón, M., Chen, T., Marcinek, D. J., Dorn, G. W., Kang, Y. J., Prolla, T. A., Santana, L. F., & Rabinovitch, P. S.
Affiliations: University of Louisville (US)
From the Departments of Pathology (D.-F.D., S.C.J., T.C., P.S.R.), Radiology (J.J.V., D.J.M.), Cardiovascular Medicine (M.T.C.), Physiology and Biophysics (M.N.-C., L.F.S.), University of Washington, Seattle; Department of Internal Medicine (G.W.D.), Washington University School of Medicine, St Louis, MO; Departments of Medicine and Pharmacology and Toxicology (Y.J.K.), University of Louisville School of Medicine, KY; and Department of Genetics and Medical Genetics (T.A.P.), University of...
ORCID: Dai, Dao-Fu
Johnson, Simon C.
Chin, Michael T.
Chen, Tony
Marcinek, David J.
Dorn, Gerald W.
Kang, Y. James
Santana, Luis F.
Rabinovitch, Peter S.
Venue: Circulation Research
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2011-04
Volume: 108
Issue: 7
Pages: 837-846
ISSN: 0009-7330 (ISSN-L)
1524-4571
DOI: 10.1161/circresaha.110.232306
PMC: PMC3785241
OpenAlex: W2117205119
Cited by: 527
References: 35
Citations by year: 2026: 14 · 2025: 35 · 2024: 30 · 2023: 32 · 2022: 28 · 2021: 42 · 2020: 46 · 2019: 34 · 2018: 31 · 2017: 29 · 2016: 44 · 2015: 34 · 2014: 37 · 2013: 36 · 2012: 41
FWCI: 16.21
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation Research (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (AG001751, AG013280)
National Institute on Aging (AG-028455, AG001751, P01AG001751, AG013280, AG035844, RC1AG035844, R01AG028455, P30AG013280)
National Heart, Lung, and Blood Institute (R01HL101186, HL-101186, R01HL063760, HL063760, R01HL059888)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Keywords: mitochondrial oxidative stress, reactive oxygen species, angiotensin II, cardiac hypertrophy, heart failure, catalase, mitochondrial DNA damage, mitochondrial DNA deletions, autophagy, mitochondrial biogenesis, hypertensive cardiomyopathy, myocardial fibrosis, zidovudine, mitochondria-targeted antioxidants
MeSH terms: Angiotensin II, Animals, Catalase, DNA Damage, DNA, Mitochondrial, Gene Expression Regulation, Cardiomegaly, Heart Failure, Mice, Transgenic, Mitochondria, Heart, Zidovudine, Reactive Oxygen Species, Oxidative Stress, Reverse Transcriptase Inhibitors, Models, Animal, Myocytes, Cardiac, GTP-Binding Protein alpha Subunits, Gq-G11, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks